Role of JNK-HuR signaling pathway in peripheral blood monocytes in ARDS

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200065500

Enrollment

Unknown

Registered

2022-11-07

Start date

2022-11-20

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ARDS

Interventions

ARDS group:N/A

Control group:N/A

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: ARDS group: 1. Aged >= 18 years, male or female; 2. Meet diagnostic criteria of ARDS in "Acute respiratory distress syndrome: the Berlin Definition2012". Control group: Healthy volunteers, aged >= 18 years, male or female.

Exclusion criteria

Exclusion criteria: Patients: 1. Received organ transplantation; 2. With malignant tumour; 3. With long-term use of hormones or immunosuppressants; 4. With hematological diseases; 5. With acquired immune deficiency syndrome (AIDS); 6. With chronic inflammatory diseases; 7. Without the consent of the patient or close relatives.

Design outcomes

Primary

Measure	Time frame
Level of protein expression;Level of cytokines expression;	—

Secondary

Measure	Time frame
Subcellular localization of HuR;	—

Countries

China

Contacts

Public ContactShi Jiaxin

Lianyungang First People's Hospital

shijiaxin909@126.com+86 18961325783

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026